Insider Transactions in Q1 2025 at Vor Biopharma Inc. (VOR)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 13
2025
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,227
-1.73%
|
$2,227
$1.42 P/Share
|
|
Feb 10
2025
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,554
-1.94%
|
$2,554
$1.37 P/Share
|
|
Feb 06
2025
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,180
-0.89%
|
$1,180
$1.5 P/Share
|
|
Feb 06
2025
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,787
-0.3%
|
$2,787
$1.5 P/Share
|
|
Feb 06
2025
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,033
-0.47%
|
$1,033
$1.5 P/Share
|
|
Feb 03
2025
|
Han Wook Choi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,500
+50.0%
|
-
|
|
Feb 03
2025
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
52,500
+28.37%
|
-
|
|
Feb 03
2025
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,353
-1.66%
|
$1,353
$1.34 P/Share
|
|
Feb 03
2025
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
52,500
+19.18%
|
-
|
|
Feb 03
2025
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-0.68%
|
$1,163
$1.34 P/Share
|
|
Feb 03
2025
|
Robert Ang PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
137,500
+12.98%
|
-
|
|
Feb 03
2025
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,248
-0.41%
|
$3,248
$1.34 P/Share
|